Information Journal Paper
APA:
Copy. (2019). Co-administration of resveratrol and beta-aminopropionitrile attenuates liver fibrosis development via targeting lysyl oxidase in CCl(4)-induced liver fibrosis in rats. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 41(6), 644-651. SID. https://sid.ir/paper/704453/en
Vancouver:
Copy. Co-administration of resveratrol and beta-aminopropionitrile attenuates liver fibrosis development via targeting lysyl oxidase in CCl(4)-induced liver fibrosis in rats. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY[Internet]. 2019;41(6):644-651. Available from: https://sid.ir/paper/704453/en
IEEE:
Copy, “Co-administration of resveratrol and beta-aminopropionitrile attenuates liver fibrosis development via targeting lysyl oxidase in CCl(4)-induced liver fibrosis in rats,” IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, vol. 41, no. 6, pp. 644–651, 2019, [Online]. Available: https://sid.ir/paper/704453/en